SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Eriksson Leif) srt2:(2020-2024)"

Sökning: WFRF:(Eriksson Leif) > (2020-2024)

  • Resultat 1-10 av 116
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Larsson-Callerfelt, Anna-Karin, et al. (författare)
  • VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation
  • 2020
  • Ingår i: Respiratory Medicine. - : Elsevier BV. - 1532-3064 .- 0954-6111. ; 166
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVES: Chronic lung allograft dysfunction including Bronchiolitis obliterans syndrome (BOS) is common after lung transplantation. Histologically, BOS is recognized as fibrotic lesions with accumulated extracellular matrix (ECM) in small airways. Lung fibroblasts are major producers of ECM and vascular endothelial growth factor (VEGF). In this study we hypothesize that VEGF is involved in BOS development after lung transplantation.METHODS: We investigated the effect of profibrotic transforming growth factor (TGF-β) on VEGF synthesis in lung fibroblasts isolated from distal lung tissue biopsies taken from patients at 3, 6 and 12 months after lung transplantation (n = 14). Co-expression of VEGF receptor (VEGFR) 2 and collagen marker prolyl4-hydroxylase (p4OH) were analyzed in lung tissue from patients with BOS (n = 11).RESULTS: VEGF synthesis from distal derived lung fibroblasts were significantly lower 3 months after lung transplantation (168.6 ± 133.7; n = 7) compared to non-transplanted subjects (451.8 ± 185.9; n = 9; p = 0.0033) and increased over time at 6 months (584.1 ± 264.9; n = 9; p = 0.0033) and 12 months (451.1 ± 207.5; n = 8; p = 0.0065) post transplantation. TGF-β significantly induced VEGF synthesis at all time points. At 12 months post transplantation there was significantly less VEGF synthesis after TGF-β stimulation in fibroblasts obtained from BOS patients (1170 ± 450.2; n = 4) compared to patients without any chronic rejection process (1980 ± 417.9; n = 4; p < 0.039). The numbers of cells expressing VEGFR2/p4OH were increased in patients with BOS (33.2 ± 10.9; n = 11) compared to control subjects (10.1 ± 9.9; n = 11; p < 0.001).CONCLUSIONS: Our results support that changes in VEGF/VEGFR2 axis could be involved in BOS development and marker of poor outcome.
  •  
2.
  • Nygren, Ulrika Svea, et al. (författare)
  • Team-based visits within Swedish child healthcare services : a national cross-sectional study
  • 2024
  • Ingår i: Journal of Interprofessional Care. - : Taylor & Francis. - 1356-1820 .- 1469-9567.
  • Tidskriftsartikel (refereegranskat)abstract
    • Complex healthcare needs can be met through effective interprofessional collaboration. Since 2014, Swedish Child Healthcare Services (CHS) include universal team-based visits with a nurse and a physician who perform such visits at the age of 4 weeks, 6 months, 12 months, and 2.5 to 3 years, as well as targeted team-based visits to address additional needs. The aim of this study was to describe the prevalence of team-based visits in the Swedish CHS and possible associations between team-based visits and contextual factors that may affect its implementation. A national cross-sectional survey was conducted using a web-based questionnaire distributed to all reachable nurses, physicians, and psychologists (n =3,552) engaged in the CHS. Data were analyzed using descriptive statistics and binary and multivariate logistic regressions. The response rate was 32%. Team-based visits were reported by 82% of the respondents. For nurses and physicians, the most frequent indication was specific ages, while for psychologists it was to provide parental support. Respondents working at Family Centers were more likely to perform team-based visits in general, at 2.5 to 3 years and in case of additional needs, compared to respondents working at Child Health Centers (CHC) and other workplaces. In conclusion, team-based visits are well implemented, but the pattern differs depending on the contextual factors. Targeted team-based visits and team-based visits at the age of 2.5 to 3 years are most unequally implemented.
  •  
3.
  • Aldenhoff, Wiebke, 1985, et al. (författare)
  • First-Year and Multiyear Sea Ice Incidence Angle Normalization of Dual-Polarized Sentinel-1 SAR Images in the Beaufort Sea
  • 2020
  • Ingår i: IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing. - 1939-1404 .- 2151-1535. ; 13, s. 1540-1550
  • Tidskriftsartikel (refereegranskat)abstract
    • Automatic and visual sea ice classification of SAR imagery is impeded by the incidence angle dependence of backscatter intensities. Knowledge of the angular dependence of different ice types is therefore necessary to account for this effect. While consistent estimates exist for HH polarization for different ice types, they are lacking HV polarization data, especially for multiyear sea ice. Here we investigate the incidence angle dependence of smooth and rough/deformed first-year and multiyear ice of different ages for wintertime dual-polarization Sentinel-1 C-band SAR imagery in the Beaufort Sea. Assuming a linear relationship, this dependence is determined using the difference in incidence angle and backscatter intensities from ascending and descending images of the same area. At cross-polarization rough/deformed first-year sea ice shows the strongest angular dependence with -text{0.11} dB/1{circ } followed by multiyear sea ice with -text{0.07} dB/text{1}{circ }, and old multiyear ice (older than three years) with -text{0.04} dB/text{1}{circ }. The noise floor is found to have a strong impact on smooth first-year ice and estimated slopes are therefore not fully reliable. At co-polarization, we obtained slope values of -0.24, -0.20, -text{0.15}, and -text{0.10} dB/text{1}{circ } for smooth first-year, rough/deformed first-year, multiyear, and old multiyear sea ice, respectively. Furthermore, we show that imperfect noise correction of the first subswath influences the obtained slopes for multiyear sea ice. We demonstrate that incidence angle normalization should not only be applied to co-polarization but should also be considered for cross-polarization images to minimize intra ice type variation in backscatter intensity throughout the entire image swath. © 2008-2012 IEEE.
  •  
4.
  • Amarasinghe, Kosala N., et al. (författare)
  • Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein response
  • 2022
  • Ingår i: Computational and Structural Biotechnology Journal. - : Elsevier BV. - 2001-0370. ; 20, s. 1584-1592
  • Tidskriftsartikel (refereegranskat)abstract
    • The unfolded protein response (UPR) is activated to cope with an accumulation of improperly folded proteins in the Endoplasmic reticulum (ER). The Inositol requiring enzyme 1 alpha (IRE1 alpha) is the most evolutionary conserved transducer of the UPR. Activated IRE1 forms 'back-to-back'-dimers that enables the unconventional splicing of X-box Binding Protein 1 (XBP1) mRNA. The spliced XBP1 (XBP1s) mRNA is translated into a transcription factor controlling the expression of UPR target genes. Herein, we report a detailed in silico screening specifically targeting for the first time the dimer interface at the IRE1 RNase region. Using the database of FDA approved drugs, we identified four compounds (neomycin, pemetrexed, quercitrin and rutin) that were able to bind to and distort IRE1 RNase cavity. The activity of the compounds on IRE1 phosphorylation was evaluated in HEK293T cells and on IRE1 RNase activity using an in vitro fluorescence assay. These analyzes revealed sub-micromolar IC50 values. The current study reveals a new and unique mode of action to target and block the IRE1-mediated UPR signaling, whereby we may avoid problems associated with selectivity occurring when targeting the IRE1 kinase pocket as well as the inherent reactivity of covalent inhibitors targeting the RNase pocket. (C)& nbsp;2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.& nbsp;
  •  
5.
  • Amarasinghe, Kosala N., et al. (författare)
  • Virtual Screening Expands the Non-Natural Amino Acid Palette for Peptide Optimization
  • 2022
  • Ingår i: Journal of Chemical Information and Modeling. - : American Chemical Society (ACS). - 1549-9596 .- 1549-960X. ; 62:12, s. 2999-3007
  • Tidskriftsartikel (refereegranskat)abstract
    • Peptides are an important modality in drug discovery. While current peptide optimization focuses predominantly on the small number of natural and commercially available non-natural amino acids, the chemical spaces available for small molecule drug discovery are in the billions of molecules. In the present study, we describe the development of a large virtual library of readily synthesizable non-natural amino acids that can power the virtual screening protocols and aid in peptide optimization. To that end, we enumerated nearly 380 thousand amino acids and demonstrated their vast chemical diversity compared to the 20 natural and commercial residues. Furthermore, we selected a diverse ten thousand amino acid subset to validate our virtual screening workflow on the Keap1-Neh2 complex model system. Through in silico mutations of Neh2 peptide residues to those from the virtual library, our docking-based protocol identified a number of possible solutions with a significantly higher predicted affinity toward the Keap1 protein. This protocol demonstrates that the non-natural amino acid chemical space can be massively extended and virtually screened with a reasonable computational cost.
  •  
6.
  • Bergquist, Filip, et al. (författare)
  • Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
  • 2022
  • Ingår i: Neurology. - : Lippincott, Williams & Wilkins. - 0028-3878 .- 1526-632X. ; 99:10, s. E965-E976
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and Objectives Intestinal levodopa/carbidopa gel infusion (LCIG) is superior to oral treatment in advanced Parkinson disease. The primary objective of this trial was to investigate whether continuous subcutaneous or intravenous infusion with a continuously buffered acidic levodopa/carbidopa solution yields steady-state plasma concentrations of levodopa that are equivalent in magnitude, and noninferior in variability, to those obtained with LCIG in patients with advanced Parkinson disease. Methods A concentrated acidic levodopa/carbidopa (8:1) solution buffered continuously and administered intravenously (DIZ101) or subcutaneously (DIZ102) was compared with an approved LCIG in a randomized, 3-period crossover, open-label, multicenter trial. Formulations were infused for 16 hours to patients with Parkinson disease who were using LCIG as their regular treatment. Patients were recruited from several university neurology clinics but came to the same phase I unit for treatment. Pharmacokinetic variables and safety including dermal tolerance are reported. The primary outcomes were bioequivalence and noninferior variability of DIZ101 and DIZ102 vs LCIG with respect to levodopa plasma concentrations. Results With dosing adjusted to estimated bioavailability, DIZ101 and DIZ102 produced levodopa plasma levels within standard bioequivalence limits compared with LCIG in the 18 participants who received all treatments. Although the levodopa bioavailability for DIZ102 was complete, it was 80% for LCIG. Therapeutic concentrations of levodopa were reached as quickly with subcutaneous administration of DIZ102 as with LCIG and remained stable throughout the infusions. Owing to poor uptake of LCIG, carbidopa levels in plasma were higher with DIZ101 and DIZ102 than with the former. All individuals receiving any of the treatments (n = 20) were included in the evaluation of safety and tolerability. Reactions at the infusion sites were mild and transient. Discussion It is feasible to rapidly achieve high and stable levodopa concentrations by means of continuous buffering of a subcutaneously administered acidic levodopa/carbidopa-containing solution.
  •  
7.
  • Bergström, Anna, 1983-, et al. (författare)
  • A facilitated social innovation : stakeholder groups using Plan-Do-Study-Act cycles for perinatal health across levels of the health system in Cao Bang province, Vietnam
  • 2023
  • Ingår i: Implementation Science Communications. - : BioMed Central (BMC). - 2662-2211. ; 4:1
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundUniversal coverage of evidence-based interventions for perinatal health, often part of evidence-based guidelines, could prevent most perinatal deaths, particularly if entire communities were engaged in the implementation. Social innovations may provide creative solutions to the implementation of evidence-based guidelines, but successful use of social innovations relies on the engagement of communities and health system actors. This proof-of-concept study aimed to assess whether an earlier successful social innovation for improved neonatal survival that employed regular facilitated Plan-Do-Study-Act meetings on the commune level was feasible and acceptable when implemented on multiple levels of the health system (52 health units) and resulted in actions with plausibly favourable effects on perinatal health and survival in Cao Bang province, northern Vietnam.MethodsThe Integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework guided the implementation and evaluation of the Perinatal Knowledge-Into-Practice (PeriKIP) project. Data collection included facilitators’ diaries, health workers’ knowledge on perinatal care, structured observations of antenatal care, focus group discussions with facilitators, their mentors and representatives of different actors of the initiated stakeholder groups and an individual interview with the Reproductive Health Centre director. Clinical experts assessed the relevance of the identified problems and actions taken based on facilitators’ diaries. Descriptive statistics included proportions, means, and t-tests for the knowledge assessment and observations. Qualitative data were analysed by content analysis.ResultsThe social innovation resulted in the identification of about 500 relevant problems. Also, 75% of planned actions to overcome prioritised problems were undertaken, results presented and a plan for new actions to achieve the group’s goals to enhance perinatal health. The facilitators had significant roles, ensuring that the stakeholder groups were established based on principles of mutual respect. Overall, the knowledge of perinatal health and performance of antenatal care improved over the intervention period.ConclusionsThe establishment of facilitated local stakeholder groups can remedy the need for tailored interventions and grassroots involvement in perinatal health and provide a scalable structure for focused efforts to reduce preventable deaths and promote health and well-being.
  •  
8.
  • Boisteau, Emeric, et al. (författare)
  • Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology
  • 2022
  • Ingår i: Oncogene. - : Springer Science and Business Media LLC. - 0950-9232 .- 1476-5594. ; 41, s. 4673-4685
  • Forskningsöversikt (refereegranskat)abstract
    • Most of the organs of the digestive tract comprise secretory epithelia that require specialized molecular machines to achieve their functions. As such anterior gradient (AGR) proteins, which comprise AGR1, AGR2, and AGR3, belong to the protein disulfide isomerase family, and are involved in secretory and transmembrane protein biogenesis in the endoplasmic reticulum. They are generally expressed in epithelial cells with high levels in most of the digestive tract epithelia. To date, the vast majority of the reports concern AGR2, which has been shown to exhibit various subcellular localizations and exert pro-oncogenic functions. AGR2 overexpression has recently been associated with a poor prognosis in digestive cancers. AGR2 is also involved in epithelial homeostasis. Its deletion in mice results in severe diffuse gut inflammation, whereas in inflammatory bowel diseases, the secretion of AGR2 in the extracellular milieu participates in the reshaping of the cellular microenvironment. AGR2 thus plays a key role in inflammation and oncogenesis and may represent a therapeutic target of interest. In this review, we summarize the already known roles and mechanisms of action of the AGR family proteins in digestive diseases, their expression in the healthy digestive tract, and in digestive oncology. At last, we discuss the potential diagnostic and therapeutic implications underlying the biology of AGR proteins.
  •  
9.
  • Bonagas, Nadilly, et al. (författare)
  • Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
  • 2022
  • Ingår i: NATURE CANCER. - : Springer Science and Business Media LLC. - 2662-1347. ; 3:2, s. 156-
  • Tidskriftsartikel (refereegranskat)abstract
    • The folate metabolism enzyme MTHFD2 (methylenetetrahydrofolate dehydrogenase/cyclohydrolase) is consistently overexpressed in cancer but its roles are not fully characterized, and current candidate inhibitors have limited potency for clinical development. In the present study, we demonstrate a role for MTHFD2 in DNA replication and genomic stability in cancer cells, and perform a drug screen to identify potent and selective nanomolar MTHFD2 inhibitors; protein cocrystal structures demonstrated binding to the active site of MTHFD2 and target engagement. MTHFD2 inhibitors reduced replication fork speed and induced replication stress followed by S-phase arrest and apoptosis of acute myeloid leukemia cells in vitro and in vivo, with a therapeutic window spanning four orders of magnitude compared with nontumorigenic cells. Mechanistically, MTHFD2 inhibitors prevented thymidine production leading to misincorporation of uracil into DNA and replication stress. Overall, these results demonstrate a functional link between MTHFD2-dependent cancer metabolism and replication stress that can be exploited therapeutically with this new class of inhibitors. Helleday and colleagues describe a nanomolar MTHFD2 inhibitor that causes replication stress and DNA damage accumulation in cancer cells via thymidine depletion, demonstrating a potential therapeutic strategy in AML tumors in vivo.
  •  
10.
  • Carlesso, Antonio, 1990, et al. (författare)
  • New insights on human IRE1 tetramer structures based on molecular modeling
  • 2020
  • Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 10:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Inositol-Requiring Enzyme 1 alpha (IRE1 alpha; hereafter IRE1) is a transmembrane kinase/ribonuclease protein related with the unfolded protein response (UPR) signaling. Experimental evidence suggests that IRE1 forms several three dimensional (3D) structural variants: dimers, tetramers and higher order oligomers, where each structural variant can contain different IRE1 conformers in different arrangements. For example, studies have shown that two sets of IRE1 dimers exist; a face-to-face dimer and a back-to-back dimer, with the latter considered the important unit for UPR signaling propagation. However, the structural configuration and mechanistic details of the biologically important IRE1 tetramers are limited. Here, we combine protein-protein docking with molecular dynamics simulations to derive human IRE1 tetramer models and identify a molecular mechanism of IRE1 activation. To validate the derived models of the human IRE1 tetramer, we compare the dynamic behavior of the models with the yeast IRE1 tetramer crystallographic structure. We show that IRE1 tetramer conformational changes could be linked to the initiation of the unconventional splicing of mRNA encoding X-box binding protein-1 (XBP1), which allows for the expression of the transcription factor XBP1s (XBP1 spliced). The derived IRE1 tetrameric models bring new mechanistic insights about the IRE1 molecular activation mechanism by describing the IRE1 tetramers as active protagonists accommodating the XBP1 substrate.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 116
Typ av publikation
tidskriftsartikel (87)
konferensbidrag (15)
doktorsavhandling (4)
forskningsöversikt (4)
rapport (2)
bokkapitel (2)
visa fler...
annan publikation (1)
licentiatavhandling (1)
visa färre...
Typ av innehåll
refereegranskat (103)
övrigt vetenskapligt/konstnärligt (12)
populärvet., debatt m.m. (1)
Författare/redaktör
Eriksson, Leif A, 19 ... (42)
Eriksson, Leif, 1970 (16)
Eriksson, Leif, 1971 ... (12)
Mahdizadeh, Sayyed J ... (11)
Carlesso, Antonio, 1 ... (10)
Chevet, E. (10)
visa fler...
Richter, Johan (6)
Olsson-Strömberg, Ul ... (6)
Stenke, Leif (6)
Myhr-Eriksson, Krist ... (6)
Söderlund, Stina (5)
Dreimane, Arta (5)
Lübking, Anna (5)
Bjermer, Leif (4)
Groop, Leif (4)
Hansson, Ola (4)
Nordgren, Lena, Doce ... (4)
Målqvist, Mats, 1971 ... (4)
Samali, A. (4)
Eriksson, Karin (4)
Pelizzari-Raymundo, ... (4)
Flygt, Hjalmar (4)
Hjorth-Hansen, Henri ... (4)
Wide, Leif (4)
Zhang, R. B. (4)
Lagerkvist, Victor, ... (4)
Höglund, Martin (3)
Lind, Lars (3)
Peterson, Stefan (3)
Eriksson, Karl-Fredr ... (3)
Tufvesson, Ellen (3)
Doultsinos, D. (3)
Gorman, A. M. (3)
Blencowe, Hannah (3)
Ankerst, Jaro (3)
Ulander, Lars, 1962 (3)
Jarenbäck, Linnea (3)
Waiswa, Peter (3)
Kwesiga, Doris (3)
Eriksson, Göran (3)
Själander, Anders (3)
Sandberg, Håkan, 195 ... (3)
Markevärn, Berit (3)
Udby, Lene (3)
Chevet, Eric (3)
Phoosuwan, Nitikorn (3)
Wang, S. D. (3)
Stentoft, Jesper (3)
Mustjoki, Satu (3)
Ekström, Ola (3)
visa färre...
Lärosäte
Göteborgs universitet (49)
Uppsala universitet (29)
Chalmers tekniska högskola (21)
Lunds universitet (19)
Karolinska Institutet (16)
Linköpings universitet (14)
visa fler...
Umeå universitet (5)
Mälardalens universitet (3)
Mittuniversitetet (3)
Kungliga Tekniska Högskolan (2)
Högskolan Dalarna (2)
Stockholms universitet (1)
Högskolan i Gävle (1)
Örebro universitet (1)
Jönköping University (1)
Högskolan i Borås (1)
Karlstads universitet (1)
VTI - Statens väg- och transportforskningsinstitut (1)
visa färre...
Språk
Engelska (113)
Svenska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (58)
Naturvetenskap (56)
Teknik (16)
Samhällsvetenskap (3)
Lantbruksvetenskap (2)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy